サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1720711

抗菌薬耐性サーベイランスの世界市場レポート 2025年

Antimicrobial Resistance Surveillance Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
抗菌薬耐性サーベイランスの世界市場レポート 2025年
出版日: 2025年05月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗菌薬耐性サーベイランス市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.5％で、101億8,000万米ドルに成長します。予測期間の成長は、抗菌薬耐性に対する意識の高まり、診断技術の進歩、政府の取り組みや資金の増加、ヘルスケア関連感染の急増、新しい抗生物質や代替治療法の開発に起因しています。主な動向としては、データ解析のための人工知能の利用、次世代シーケンシング技術、リアルタイム監視システム、分子診断ツール、予測モデリングのためのビッグデータと機械学習の統合などが挙げられます。

感染症の流行の増加は、抗菌薬耐性サーベイランス市場の成長を促進すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの有害な微生物によって引き起こされ、個人間で直接的または間接的に広がる可能性があります。気候変動、都市化、世界の旅行などの要因は、病原体の感染を促進し、新たな微生物にヒトがさらされる機会を増やすことで、これらの疾病の有病率の上昇に寄与しています。抗菌薬耐性サーベイランスは、耐性病原体の蔓延を追跡し、効果的な治療戦略を導き、感染症と闘うための公衆衛生政策を形成する上で極めて重要な役割を果たしています。例えば、2024年2月、英国健康安全保障庁の報告書により、イングランドにおける結核症例が10.7％増加し、2022年の4,380例に比べ、2023年には4,850例が報告されたことが明らかになりました。その結果、感染症の蔓延が抗菌薬耐性サーベイランス市場の拡大に拍車をかけています。

業界の主要企業は、効率改善、精度向上、コスト削減、患者転帰改善のために、先進的診断ツールなどの革新的技術に注力しています。診断ツールには、状態、疾患、機能不全の検出、特定、評価に使用されるあらゆる装置、機器、ソフトウェア、手法が含まれます。例えば、2023年6月、スウェーデンに本拠を置く診断製品メーカーであるSysmex Astrego ABは、PA-100 AST Point-of-Care Testing Systemを発売しました。このシステムは、抗菌薬耐性をポイントオブケアで迅速かつ正確に検出することを可能にし、数日を要する従来の検査法に比べ、結果が出るまでの時間を大幅に短縮します。わずか30分で結果が得られるため、臨床医は感染症治療に関してタイムリーで十分な情報に基づいた決定を下すことができ、広域抗生物質への依存を最小限に抑え、抗菌薬耐性を抑制する取り組みに貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界抗菌薬耐性サーベイランス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の抗菌薬耐性サーベイランス市場：成長率分析
  • 世界の抗菌薬耐性サーベイランス市場の実績：規模と成長, 2019-2024
  • 世界の抗菌薬耐性サーベイランス市場の予測：規模と成長, 2024-2029, 2034F
  • 世界抗菌薬耐性サーベイランス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の抗菌薬耐性サーベイランス市場：ソリューション別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断キット
  • 診断システム
  • 監視ソフトウェア
  • サービス
  • 世界の抗菌薬耐性サーベイランス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 臨床診断
  • 公衆衛生監視
  • その他の用途
  • 世界の抗菌薬耐性サーベイランス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院と診療所
  • 調査・学術機関
  • その他のエンドユーザー
  • 世界の抗菌薬耐性サーベイランス市場診断キットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • PCRベースのキット
  • 免疫測定キット
  • ラテラルフローアッセイキット
  • 世界の抗菌薬耐性サーベイランス市場診断システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 自動感受性試験システム
  • 全ゲノムシークエンシング（WGS）システム
  • 質量分析ベースのシステム
  • 世界の抗菌薬耐性サーベイランス市場監視ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • クラウドベースの監視プラットフォーム
  • AIを活用したデータ分析ツール
  • 電子健康記録（EHR）統合システム
  • 世界の抗菌薬耐性サーベイランス市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ラボ試験サービス
  • データ管理およびレポートサービス
  • コンサルティングおよびトレーニングサービス

第7章 地域別・国別分析

  • 世界の抗菌薬耐性サーベイランス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の抗菌薬耐性サーベイランス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 抗菌薬耐性サーベイランス市場：競合情勢
  • 抗菌薬耐性サーベイランス市場：企業プロファイル
    • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Viatris Inc.
  • Wolters Kluwer NV
  • Hologic Inc.
  • Biomerieux SA
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Qiagen NV
  • Cepheid Inc.
  • Shionogi & Co. Ltd.
  • Venatorx Pharmaceuticals Inc.
  • Accelerate Diagnostics Inc.
  • Paratek Pharmaceuticals Inc.
  • Liofilchem Srl
  • Lumed Inc.
  • OpGen Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 抗菌薬耐性サーベイランス市場2029：新たな機会を提供する国
  • 抗菌薬耐性サーベイランス市場2029：新たな機会を提供するセグメント
  • 抗菌薬耐性サーベイランス市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33966

Antimicrobial resistance (AMR) surveillance involves the systematic monitoring and tracking of antimicrobial-resistant microorganisms to detect emerging resistance patterns, guide public health interventions, and inform treatment strategies for infections caused by resistant bacteria, viruses, and fungi.

The primary solutions in AMR surveillance include diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are pre-packaged tools that enable healthcare professionals to rapidly identify antimicrobial-resistant infections in patients. These solutions are applied in clinical diagnostics, public health surveillance, and other areas, serving end users such as hospitals and clinics, research and academic institutes, and other healthcare facilities.

The antimicrobial resistance surveillance market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance surveillance market statistics, including antimicrobial resistance surveillance industry global market size, regional shares, competitors with an antimicrobial resistance surveillance market share, detailed antimicrobial resistance surveillance market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance surveillance industry. This antimicrobial resistance surveillance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the increased use of antibiotics in agriculture, the overprescription of antibiotics in healthcare, a lack of diagnostic testing, inadequate infection prevention and control practices, and the impact of global travel and trade.

The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing awareness of antimicrobial resistance, advancements in diagnostic technologies, rising government initiatives and funding, a surge in healthcare-associated infections, and the development of new antibiotics and alternative treatments. Key trends include the use of artificial intelligence for data analysis, next-generation sequencing technologies, real-time surveillance systems, molecular diagnostic tools, and the integration of big data and machine learning for predictive modeling.

The increasing prevalence of infectious diseases is expected to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly between individuals. Factors such as climate change, urbanization, and global travel contribute to the rising prevalence of these diseases by facilitating pathogen transmission and increasing human exposure to new microbes. Antimicrobial resistance surveillance plays a crucial role in tracking the spread of resistant pathogens, guiding effective treatment strategies, and shaping public health policies to combat infectious diseases. For example, in February 2024, a report by the UK Health Security Agency revealed a 10.7% increase in tuberculosis (TB) cases in England, with 4,850 cases reported in 2023 compared to 4,380 in 2022. As a result, the increasing prevalence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.

Leading companies in the industry are focusing on innovative technologies, such as advanced diagnostic tools, to improve efficiency, enhance accuracy, reduce costs, and provide better patient outcomes. A diagnostic tool encompasses any device, instrument, software, or methodology used to detect, identify, or assess the presence of a condition, disease, or malfunction. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer of diagnostic products, launched the PA-100 AST Point-of-Care Testing System. This system enables rapid and precise detection of antimicrobial resistance at the point of care, significantly reducing the time required for results compared to conventional laboratory methods, which can take several days. By delivering results in just 30 minutes, it empowers clinicians to make timely and informed decisions regarding infection treatment, minimizing reliance on broad-spectrum antibiotics and aiding efforts to curb antimicrobial resistance.

In January 2024, BioMerieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. This acquisition is aimed at enhancing BioMerieux's capabilities in combating antimicrobial resistance and strengthening its portfolio, particularly by offering digital tools to support antibiotic stewardship. LUMED Inc., an Italy-based company, specializes in healthcare and medical data analysis, with a focus on antimicrobial resistance surveillance.

Major players in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.

North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance surveillance report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial resistance surveillance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Resistance Surveillance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial resistance surveillance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial resistance surveillance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antimicrobial resistance surveillance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
  • 2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
  • 3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
  • Subsegments:
  • 1) By Diagnostic Kits: PCR-Based Kits; Immunoassay Kits; Lateral Flow Assay Kits
  • 2) By Diagnostic Systems: Automated Susceptibility Testing Systems; Whole Genome Sequencing (WGS) Systems; Mass Spectrometry-Based Systems
  • 3) By Surveillance Software: Cloud-Based Surveillance Platforms; AI-Powered Data Analytics Tools; Electronic Health Record (EHR)-Integrated Systems
  • 4) By Services: Laboratory Testing Services; Data Management & Reporting Services; Consultation & Training Services
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antimicrobial Resistance Surveillance Market Characteristics

3. Antimicrobial Resistance Surveillance Market Trends And Strategies

4. Antimicrobial Resistance Surveillance Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Antimicrobial Resistance Surveillance Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Antimicrobial Resistance Surveillance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Antimicrobial Resistance Surveillance Market Growth Rate Analysis
  • 5.4. Global Antimicrobial Resistance Surveillance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Antimicrobial Resistance Surveillance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Antimicrobial Resistance Surveillance Total Addressable Market (TAM)

6. Antimicrobial Resistance Surveillance Market Segmentation

  • 6.1. Global Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Kits
  • Diagnostic Systems
  • Surveillance Software
  • Services
  • 6.2. Global Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Diagnostics
  • Public Health Surveillance
  • Other Applications
  • 6.3. Global Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Research And Academic Institutes
  • Other End Users
  • 6.4. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR-Based Kits
  • Immunoassay Kits
  • Lateral Flow Assay Kits
  • 6.5. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Susceptibility Testing Systems
  • Whole Genome Sequencing (WGS) Systems
  • Mass Spectrometry-Based Systems
  • 6.6. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Surveillance Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based Surveillance Platforms
  • AI-Powered Data Analytics Tools
  • Electronic Health Record (EHR)-Integrated Systems
  • 6.7. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Services
  • Data Management And Reporting Services
  • Consultation And Training Services

7. Antimicrobial Resistance Surveillance Market Regional And Country Analysis

  • 7.1. Global Antimicrobial Resistance Surveillance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Antimicrobial Resistance Surveillance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Resistance Surveillance Market

  • 8.1. Asia-Pacific Antimicrobial Resistance Surveillance Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Resistance Surveillance Market

  • 9.1. China Antimicrobial Resistance Surveillance Market Overview
  • 9.2. China Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Resistance Surveillance Market

  • 10.1. India Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Resistance Surveillance Market

  • 11.1. Japan Antimicrobial Resistance Surveillance Market Overview
  • 11.2. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Resistance Surveillance Market

  • 12.1. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Resistance Surveillance Market

  • 13.1. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Resistance Surveillance Market

  • 14.1. South Korea Antimicrobial Resistance Surveillance Market Overview
  • 14.2. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Resistance Surveillance Market

  • 15.1. Western Europe Antimicrobial Resistance Surveillance Market Overview
  • 15.2. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Resistance Surveillance Market

  • 16.1. UK Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Resistance Surveillance Market

  • 17.1. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Resistance Surveillance Market

  • 18.1. France Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Resistance Surveillance Market

  • 19.1. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Resistance Surveillance Market

  • 20.1. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Resistance Surveillance Market

  • 21.1. Eastern Europe Antimicrobial Resistance Surveillance Market Overview
  • 21.2. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Resistance Surveillance Market

  • 22.1. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Resistance Surveillance Market

  • 23.1. North America Antimicrobial Resistance Surveillance Market Overview
  • 23.2. North America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Resistance Surveillance Market

  • 24.1. USA Antimicrobial Resistance Surveillance Market Overview
  • 24.2. USA Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Resistance Surveillance Market

  • 25.1. Canada Antimicrobial Resistance Surveillance Market Overview
  • 25.2. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Resistance Surveillance Market

  • 26.1. South America Antimicrobial Resistance Surveillance Market Overview
  • 26.2. South America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Resistance Surveillance Market

  • 27.1. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Resistance Surveillance Market

  • 28.1. Middle East Antimicrobial Resistance Surveillance Market Overview
  • 28.2. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Resistance Surveillance Market

  • 29.1. Africa Antimicrobial Resistance Surveillance Market Overview
  • 29.2. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Resistance Surveillance Market Competitive Landscape And Company Profiles

  • 30.1. Antimicrobial Resistance Surveillance Market Competitive Landscape
  • 30.2. Antimicrobial Resistance Surveillance Market Company Profiles
    • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Resistance Surveillance Market Other Major And Innovative Companies

  • 31.1. Viatris Inc.
  • 31.2. Wolters Kluwer NV
  • 31.3. Hologic Inc.
  • 31.4. Biomerieux SA
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Bruker Corporation
  • 31.7. Qiagen NV
  • 31.8. Cepheid Inc.
  • 31.9. Shionogi & Co. Ltd.
  • 31.10. Venatorx Pharmaceuticals Inc.
  • 31.11. Accelerate Diagnostics Inc.
  • 31.12. Paratek Pharmaceuticals Inc.
  • 31.13. Liofilchem Srl
  • 31.14. Lumed Inc.
  • 31.15. OpGen Inc.

32. Global Antimicrobial Resistance Surveillance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Resistance Surveillance Market

34. Recent Developments In The Antimicrobial Resistance Surveillance Market

35. Antimicrobial Resistance Surveillance Market High Potential Countries, Segments and Strategies

  • 35.1 Antimicrobial Resistance Surveillance Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Antimicrobial Resistance Surveillance Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Antimicrobial Resistance Surveillance Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer